Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Jazz Pharmaceuticals Falls on 7.88 Million Share Offering

Jazz Pharmaceuticals Plc, maker of the narcolepsy medicine Xyrem, declined in New York trading after the company reported a public offering of 7.88 million shares by some stockholders.

Jazz dropped 5.1 percent to $48.72 at 4 p.m. The shares of the Dublin-based company have gained 80 percent in the last 12 months. The drugmaker also has offices in Palo Alto, California, and Philadelphia.

Barclays Plc and Citigroup Inc. are leading the offering, Jazz said yesterday in a statement. The company won’t receive any proceeds from the sale, and the total number of shares outstanding won’t change.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.